Effects of Amide Creatine Derivatives in Brain Hippocampal Slices, and Their Possible Usefulness for Curing Creatine Transporter Deficiency

被引:11
作者
Garbati, Patrizia [1 ]
Adriano, Enrico [1 ]
Salis, Annalisa [2 ,3 ]
Ravera, Silvia [4 ]
Damonte, Gianluca [3 ,5 ]
Millo, Enrico [3 ,5 ]
Balestrino, Maurizio [1 ]
机构
[1] Univ Genoa, Dept Neurosci Ophthalmol Genet Maternal Infantile, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Hearth Environm & Life Sci DISTAV, I-16132 Genoa, Italy
[3] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy
[4] Univ Genoa, Dept Pharm DIFAR, Biochem Lab, I-16132 Genoa, Italy
[5] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy
关键词
Creatine; Creatine transporter deficiency; Creatine derivatives; Neuroprotection; Glycine damage; Hippocampal slices; MENTAL-RETARDATION; SYNAPTIC-TRANSMISSION; DAMAGE; PHOSPHOCREATINE; PREVALENCE; PROTECTION; ANOXIA; TISSUE; MALES; MODEL;
D O I
10.1007/s11064-013-1188-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The creatine/phosphocreatine system carries ATP from production to consumption sites and buffers the intracellular content of ATP at times of energy deprivation. The creatine transporter deficiency syndrome is an X-linked disease caused by a defective creatine transporter into the central nervous system. This disease is presently untreatable because creatine lacking its carrier cannot cross neither the blood-brain barrier nor the cell plasma membranes. Possible strategies to cure this condition are to couple creatine to molecules which have their own carrier, to exploit the latter to cross biological membranes or to modify the creatine molecule to make it more lipophilic, in such a way that it may more easily cross lipid-rich biological membranes. Such molecules could moreover be useful for treatment of stroke or other ischemic brain syndromes of normal (transporter working) tissue. In this paper we tested four molecules in in vitro hippocampal slices experiments to investigate whether or not they had a neuroprotective effect similar to that of creatine. On two of them we also performed biochemical measurements to investigate whether or not they were able to increase the creatine and phosphocreatine content of the hippocampal slices with and without block of the transporter. We found that these molecules increase levels of creatine after block of the transporter, and significantly increased the levels of phosphocreatine. Both significantly increased the total creatine content in both conditions of active and blocked transporter. This shows that these molecules are capable of entering cells through biological membranes without using the creatine transporter. By contrast, neither of them was able to delay synaptic block during anoxia of normal (transporter functioning) tissue. We conclude that these compounds might possibly be useful for therapy of creatine transporter deficiency, but further research is needed to understand their possible role in anoxia/ischemia of normal tissue.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 38 条
[1]   Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases [J].
Adhihetty, Peter J. ;
Beal, M. Flint .
NEUROMOLECULAR MEDICINE, 2008, 10 (04) :275-290
[2]   SEARCHING FOR A THERAPY OF CREATINE TRANSPORTER DEFICIENCY: SOME EFFECTS OF CREATINE ETHYL ESTER IN BRAIN SLICES IN VITRO [J].
Adriano, E. ;
Garbati, P. ;
Damonte, G. ;
Salis, A. ;
Armirotti, A. ;
Balestrino, M. .
NEUROSCIENCE, 2011, 199 :386-393
[3]  
ANDERSEN P, 1971, EXP BRAIN RES, V13, P208
[4]   Creatine transporter deficiency:: Prevalence among patients with mental retardation and pitfalls in metabolite screening [J].
Arias, Angela ;
Corbella, Marc ;
Fons, Carmen ;
Sempere, Angela ;
Garcia-Villoria, Judit ;
Ormazabal, Aida ;
Poo, Pilar ;
Pineda, Merce ;
Vilaseca, Maria Antonia ;
Campistol, Jaume ;
Briones, Paz ;
Pampols, Teresa ;
Salomons, Gajja S. ;
Ribes, Antonia ;
Artuch, Rafael .
CLINICAL BIOCHEMISTRY, 2007, 40 (16-17) :1328-1331
[5]   Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship [J].
Balestrino, M ;
Rebaudo, R ;
Lunardi, G .
BRAIN RESEARCH, 1999, 816 (01) :124-130
[6]   Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage [J].
Balestrino, M ;
Lensman, M ;
Parodi, M ;
Perasso, L ;
Rebaudo, R ;
Melani, R ;
Polenov, S ;
Cupello, A .
AMINO ACIDS, 2002, 23 (1-3) :221-229
[7]  
Ballanyi K., 1999, Modern Techniques in Neuroscience Research, P307
[8]   Glycine-induced neurotoxicity in organotypic hippocampal slice cultures [J].
Barth, A ;
Nguyen, LB ;
Barth, L ;
Newell, DW .
EXPERIMENTAL BRAIN RESEARCH, 2005, 161 (03) :351-357
[9]   Neuroprotective effects of creatine [J].
Beal, M. Flint .
AMINO ACIDS, 2011, 40 (05) :1305-1313
[10]  
Bergmeyer H., 1974, Methods Enzymatic Anal, V3, P1205